Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Vasc Interv Radiol. 2018 Dec 6;30(1):19–22. doi: 10.1016/j.jvir.2018.06.023

Table 2:

Adverse Events Ranked by Observation Frequency

Adverse Event Max CTCAE grade No. of Patients
(VAR,WT)
Lymphopenia 4 3 (2,1)
Anemia 3 3 (1,2)
Abdominal Pain 3 2 (1,1)
Anorexia 2 2 (2,0)
Elevated Transaminases 3 2 (1,1)
Fever 2 2 (2,0)
Pruritis 2 1 (1,0)
Vomiting 2 1 (0,1)
Weight Loss 2 1 (1,0)
Thromboembolic Event 3 1 (1,0)
Death 5 1 (0,1)